| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cranial Irradiation | 6 | 2021 | 69 | 1.940 |
Why?
|
| Radiation Exposure | 3 | 2024 | 43 | 1.700 |
Why?
|
| Radiation Injuries, Experimental | 4 | 2017 | 23 | 1.590 |
Why?
|
| Bone Marrow | 3 | 2017 | 322 | 1.420 |
Why?
|
| Glioma | 6 | 2019 | 491 | 1.150 |
Why?
|
| Brain Neoplasms | 10 | 2019 | 1217 | 1.110 |
Why?
|
| Leukocytes | 6 | 2024 | 207 | 0.980 |
Why?
|
| Rats | 21 | 2021 | 3631 | 0.970 |
Why?
|
| Radiation Protection | 3 | 2022 | 54 | 0.910 |
Why?
|
| Brain | 12 | 2021 | 2947 | 0.820 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 53 | 0.720 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2019 | 1211 | 0.680 |
Why?
|
| Radiation Injuries | 2 | 2022 | 142 | 0.680 |
Why?
|
| Hematologic Tests | 1 | 2019 | 34 | 0.680 |
Why?
|
| Encephalitis | 1 | 2020 | 108 | 0.660 |
Why?
|
| Animals | 49 | 2024 | 33741 | 0.660 |
Why?
|
| Neurogenesis | 3 | 2022 | 196 | 0.660 |
Why?
|
| Blood Chemical Analysis | 1 | 2019 | 77 | 0.660 |
Why?
|
| Multimodal Imaging | 2 | 2017 | 113 | 0.640 |
Why?
|
| Behavior, Animal | 1 | 2020 | 477 | 0.600 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 554 | 0.590 |
Why?
|
| Mannans | 1 | 2017 | 11 | 0.580 |
Why?
|
| Wound Healing | 2 | 2014 | 452 | 0.580 |
Why?
|
| Bystander Effect | 1 | 2017 | 7 | 0.580 |
Why?
|
| Prebiotics | 1 | 2017 | 23 | 0.570 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 91 | 0.560 |
Why?
|
| Cell Proliferation | 5 | 2020 | 2308 | 0.550 |
Why?
|
| Microcirculation | 6 | 2006 | 93 | 0.550 |
Why?
|
| Machine Learning | 1 | 2019 | 220 | 0.550 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2018 | 135 | 0.550 |
Why?
|
| Neurotransmitter Agents | 1 | 2017 | 139 | 0.540 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 77 | 0.530 |
Why?
|
| Dideoxynucleosides | 1 | 2015 | 8 | 0.510 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 156 | 0.510 |
Why?
|
| Blood-Brain Barrier | 5 | 2011 | 141 | 0.500 |
Why?
|
| Body Weight | 3 | 2016 | 999 | 0.500 |
Why?
|
| Allergens | 1 | 2017 | 245 | 0.490 |
Why?
|
| Ferrosoferric Oxide | 1 | 2015 | 26 | 0.490 |
Why?
|
| Bone Marrow Diseases | 1 | 2015 | 39 | 0.490 |
Why?
|
| Hippocampus | 3 | 2022 | 812 | 0.480 |
Why?
|
| Mechanical Phenomena | 1 | 2014 | 15 | 0.480 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 208 | 0.480 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2020 | 670 | 0.470 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 4268 | 0.470 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 423 | 0.470 |
Why?
|
| Growth Disorders | 1 | 2016 | 206 | 0.470 |
Why?
|
| Cognition Disorders | 1 | 2018 | 554 | 0.440 |
Why?
|
| Mice | 26 | 2024 | 17498 | 0.430 |
Why?
|
| Radiation Dosage | 4 | 2024 | 132 | 0.430 |
Why?
|
| Male | 31 | 2024 | 60021 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 4352 | 0.360 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2009 | 133 | 0.360 |
Why?
|
| Skin Physiological Phenomena | 1 | 2010 | 19 | 0.350 |
Why?
|
| Whole-Body Irradiation | 2 | 2024 | 65 | 0.350 |
Why?
|
| Gliosis | 3 | 2020 | 32 | 0.350 |
Why?
|
| Asthma | 1 | 2017 | 746 | 0.340 |
Why?
|
| Ependymoma | 2 | 2008 | 133 | 0.330 |
Why?
|
| Fluorescein-5-isothiocyanate | 4 | 2009 | 30 | 0.320 |
Why?
|
| Radiation Tolerance | 3 | 2018 | 52 | 0.320 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2021 | 239 | 0.300 |
Why?
|
| Islets of Langerhans | 2 | 2024 | 173 | 0.290 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 281 | 0.280 |
Why?
|
| Models, Biological | 2 | 2010 | 1442 | 0.280 |
Why?
|
| Rats, Wistar | 3 | 2017 | 359 | 0.280 |
Why?
|
| Microfilament Proteins | 2 | 2020 | 277 | 0.270 |
Why?
|
| Ellagic Acid | 3 | 2010 | 4 | 0.260 |
Why?
|
| Abdominal Injuries | 1 | 2006 | 108 | 0.250 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2007 | 576 | 0.250 |
Why?
|
| Chitosan | 3 | 2010 | 21 | 0.250 |
Why?
|
| Sirolimus | 1 | 2006 | 220 | 0.240 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 317 | 0.230 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 671 | 0.230 |
Why?
|
| Blood Cell Count | 1 | 2024 | 69 | 0.230 |
Why?
|
| Hyperinsulinism | 1 | 2024 | 68 | 0.220 |
Why?
|
| Cytokines | 2 | 2008 | 1284 | 0.220 |
Why?
|
| Time Factors | 6 | 2019 | 6201 | 0.220 |
Why?
|
| Oxygen | 2 | 2007 | 540 | 0.220 |
Why?
|
| Craniotomy | 1 | 2004 | 107 | 0.220 |
Why?
|
| Microscopy | 1 | 2004 | 118 | 0.220 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 11 | 0.200 |
Why?
|
| Insulin-Secreting Cells | 1 | 2024 | 145 | 0.200 |
Why?
|
| Adaptation, Physiological | 2 | 2021 | 261 | 0.200 |
Why?
|
| Astronauts | 1 | 2022 | 49 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 3518 | 0.190 |
Why?
|
| Biomechanical Phenomena | 2 | 2014 | 246 | 0.190 |
Why?
|
| Cell Death | 2 | 2020 | 242 | 0.190 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2017 | 68 | 0.190 |
Why?
|
| Protons | 1 | 2021 | 91 | 0.190 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2020 | 34 | 0.180 |
Why?
|
| Neoplasm Transplantation | 3 | 2017 | 369 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 30 | 0.180 |
Why?
|
| Cyclohexanones | 1 | 2020 | 19 | 0.180 |
Why?
|
| Malignant Hyperthermia | 1 | 2020 | 19 | 0.180 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2020 | 123 | 0.180 |
Why?
|
| HMGB1 Protein | 1 | 2020 | 33 | 0.180 |
Why?
|
| Ki-67 Antigen | 1 | 2020 | 113 | 0.180 |
Why?
|
| Endothelium, Vascular | 4 | 2011 | 515 | 0.180 |
Why?
|
| Space Flight | 1 | 2022 | 114 | 0.180 |
Why?
|
| Interferon-beta | 3 | 2010 | 50 | 0.180 |
Why?
|
| Apoptosis | 3 | 2020 | 1783 | 0.180 |
Why?
|
| Metabolic Syndrome | 1 | 2024 | 329 | 0.180 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 101 | 0.180 |
Why?
|
| Thermogenesis | 1 | 2020 | 44 | 0.180 |
Why?
|
| Chloride Channels | 1 | 2020 | 62 | 0.180 |
Why?
|
| Muscle, Skeletal | 2 | 2004 | 939 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2012 | 414 | 0.170 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 175 | 0.170 |
Why?
|
| Random Allocation | 1 | 2020 | 423 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 327 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 3 | 2010 | 240 | 0.160 |
Why?
|
| Receptors, Steroid | 1 | 2020 | 269 | 0.160 |
Why?
|
| Pyridines | 1 | 2020 | 223 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2021 | 262 | 0.160 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2020 | 232 | 0.150 |
Why?
|
| Rats, Inbred F344 | 1 | 2018 | 102 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 222 | 0.150 |
Why?
|
| Radiotherapy Dosage | 2 | 2017 | 185 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2017 | 2 | 0.150 |
Why?
|
| Taurine | 1 | 2017 | 10 | 0.150 |
Why?
|
| Airway Remodeling | 1 | 2017 | 21 | 0.150 |
Why?
|
| Mannose-Binding Lectins | 1 | 2017 | 24 | 0.150 |
Why?
|
| Drug Delivery Systems | 3 | 2010 | 182 | 0.140 |
Why?
|
| Cognition | 3 | 2022 | 735 | 0.140 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 789 | 0.140 |
Why?
|
| Positron-Emission Tomography | 2 | 2018 | 287 | 0.140 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 540 | 0.140 |
Why?
|
| Bone Neoplasms | 2 | 2021 | 427 | 0.140 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 69 | 0.140 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 134 | 0.140 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 136 | 0.140 |
Why?
|
| Sarcoma, Ewing | 1 | 2018 | 113 | 0.140 |
Why?
|
| Allografts | 1 | 2017 | 190 | 0.140 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 167 | 0.130 |
Why?
|
| Venules | 2 | 2013 | 25 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 288 | 0.130 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 893 | 0.130 |
Why?
|
| X-Rays | 1 | 2015 | 27 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1216 | 0.130 |
Why?
|
| Magnetics | 1 | 2015 | 41 | 0.130 |
Why?
|
| Peptide Hormones | 1 | 2016 | 66 | 0.120 |
Why?
|
| Astrocytes | 2 | 2009 | 250 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 469 | 0.120 |
Why?
|
| Algorithms | 3 | 2019 | 1597 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 414 | 0.120 |
Why?
|
| Cell Adhesion | 7 | 2011 | 321 | 0.120 |
Why?
|
| Cell Line, Tumor | 8 | 2018 | 3289 | 0.120 |
Why?
|
| Kinetics | 1 | 2017 | 1313 | 0.120 |
Why?
|
| Platelet Count | 1 | 2014 | 133 | 0.120 |
Why?
|
| Fasting | 1 | 2016 | 296 | 0.120 |
Why?
|
| Animals, Newborn | 1 | 2018 | 991 | 0.120 |
Why?
|
| Mesocricetus | 3 | 2003 | 71 | 0.120 |
Why?
|
| Quinic Acid | 1 | 2013 | 2 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 70 | 0.110 |
Why?
|
| Cell Communication | 3 | 2021 | 165 | 0.110 |
Why?
|
| Humans | 24 | 2022 | 123199 | 0.110 |
Why?
|
| Age Factors | 1 | 2020 | 2801 | 0.110 |
Why?
|
| Radiation-Protective Agents | 1 | 2013 | 17 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1225 | 0.110 |
Why?
|
| Cricetinae | 3 | 2003 | 410 | 0.110 |
Why?
|
| Inflammation | 2 | 2020 | 1404 | 0.110 |
Why?
|
| Nonlinear Dynamics | 2 | 2010 | 51 | 0.110 |
Why?
|
| Biopsy | 1 | 2017 | 1239 | 0.110 |
Why?
|
| Vascular System Injuries | 1 | 2013 | 50 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 998 | 0.110 |
Why?
|
| Tumor Burden | 2 | 2011 | 230 | 0.100 |
Why?
|
| Nanoshells | 1 | 2012 | 13 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2013 | 139 | 0.100 |
Why?
|
| Osteoblasts | 1 | 2013 | 149 | 0.100 |
Why?
|
| Oxygen Consumption | 2 | 2010 | 303 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2016 | 748 | 0.100 |
Why?
|
| Phototherapy | 1 | 2012 | 35 | 0.100 |
Why?
|
| Hyperthermia, Induced | 1 | 2012 | 44 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 2 | 2010 | 211 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2015 | 459 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2391 | 0.100 |
Why?
|
| Skin | 1 | 2014 | 506 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 2043 | 0.090 |
Why?
|
| In Vitro Techniques | 2 | 2010 | 966 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2014 | 1470 | 0.090 |
Why?
|
| Dextrans | 3 | 2009 | 46 | 0.090 |
Why?
|
| Radiotherapy, Conformal | 2 | 2008 | 55 | 0.090 |
Why?
|
| Arthritis, Experimental | 1 | 2010 | 15 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 576 | 0.090 |
Why?
|
| Collagen Type II | 1 | 2010 | 24 | 0.090 |
Why?
|
| Camptothecin | 1 | 2010 | 76 | 0.090 |
Why?
|
| Finite Element Analysis | 1 | 2010 | 28 | 0.090 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2010 | 31 | 0.090 |
Why?
|
| Recombinant Proteins | 5 | 2016 | 1390 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1684 | 0.090 |
Why?
|
| Glycerophosphates | 1 | 2010 | 3 | 0.090 |
Why?
|
| Anisotropy | 1 | 2010 | 122 | 0.090 |
Why?
|
| Elasticity | 1 | 2010 | 92 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 102 | 0.090 |
Why?
|
| Fibrin | 1 | 2010 | 67 | 0.090 |
Why?
|
| Endothelial Cells | 3 | 2012 | 528 | 0.090 |
Why?
|
| Gels | 1 | 2010 | 60 | 0.090 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 1 | 2010 | 37 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 171 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 306 | 0.080 |
Why?
|
| Antibodies | 2 | 2016 | 370 | 0.080 |
Why?
|
| Models, Animal | 2 | 2011 | 465 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2487 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 123 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 208 | 0.070 |
Why?
|
| Arterioles | 2 | 2009 | 27 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2008 | 208 | 0.070 |
Why?
|
| Receptors, Collagen | 1 | 2007 | 7 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2010 | 605 | 0.070 |
Why?
|
| Tight Junctions | 2 | 2004 | 37 | 0.070 |
Why?
|
| Tensile Strength | 1 | 2006 | 38 | 0.070 |
Why?
|
| Capillary Permeability | 2 | 2006 | 78 | 0.070 |
Why?
|
| Cell Wall | 1 | 2006 | 34 | 0.070 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 31 | 0.070 |
Why?
|
| Mutation | 1 | 2020 | 5778 | 0.070 |
Why?
|
| Osteogenesis | 2 | 2021 | 153 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2008 | 1011 | 0.070 |
Why?
|
| Female | 9 | 2021 | 65432 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2010 | 673 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1305 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2020 | 878 | 0.060 |
Why?
|
| E-Selectin | 1 | 2005 | 42 | 0.060 |
Why?
|
| Insulin | 2 | 2024 | 1197 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2007 | 257 | 0.060 |
Why?
|
| P-Selectin | 1 | 2005 | 77 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 1194 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2007 | 294 | 0.060 |
Why?
|
| Pia Mater | 1 | 2004 | 9 | 0.060 |
Why?
|
| Spermatic Cord | 1 | 2004 | 12 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2024 | 3717 | 0.060 |
Why?
|
| Proinsulin | 1 | 2024 | 12 | 0.060 |
Why?
|
| Rhodamines | 1 | 2004 | 22 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 281 | 0.060 |
Why?
|
| Pneumococcal Infections | 1 | 2006 | 274 | 0.060 |
Why?
|
| Cell Membrane Permeability | 1 | 2004 | 73 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2003 | 448 | 0.060 |
Why?
|
| Osteocalcin | 1 | 2024 | 40 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2006 | 374 | 0.060 |
Why?
|
| Glucagon | 1 | 2024 | 185 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2005 | 272 | 0.060 |
Why?
|
| Mice, SCID | 3 | 2010 | 572 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2024 | 116 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2005 | 868 | 0.050 |
Why?
|
| Abdominal Muscles | 1 | 2003 | 27 | 0.050 |
Why?
|
| Guanidines | 1 | 2003 | 25 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2397 | 0.050 |
Why?
|
| Biological Availability | 1 | 2003 | 128 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 12 | 0.050 |
Why?
|
| Acetylcholine | 1 | 2003 | 82 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 94 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 645 | 0.050 |
Why?
|
| Base Sequence | 2 | 2007 | 3093 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 185 | 0.050 |
Why?
|
| Radiation, Ionizing | 3 | 2010 | 42 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 208 | 0.050 |
Why?
|
| Gene Expression | 2 | 2007 | 1569 | 0.050 |
Why?
|
| Melanoma | 1 | 2009 | 836 | 0.050 |
Why?
|
| Thrombosis | 1 | 2007 | 520 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2003 | 206 | 0.050 |
Why?
|
| Vasodilation | 1 | 2003 | 191 | 0.050 |
Why?
|
| Growth Hormone | 1 | 2002 | 149 | 0.050 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 225 | 0.050 |
Why?
|
| Infant | 3 | 2020 | 12323 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2021 | 38 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2002 | 102 | 0.050 |
Why?
|
| Weight Gain | 1 | 2024 | 401 | 0.050 |
Why?
|
| Clonal Evolution | 1 | 2021 | 38 | 0.050 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 57 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 36 | 0.050 |
Why?
|
| Heart Function Tests | 1 | 2020 | 57 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2020 | 13862 | 0.050 |
Why?
|
| Uncoupling Protein 1 | 1 | 2020 | 29 | 0.050 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 31 | 0.050 |
Why?
|
| Lactates | 1 | 2020 | 89 | 0.050 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 222 | 0.040 |
Why?
|
| Restraint, Physical | 1 | 2000 | 28 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 878 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2002 | 216 | 0.040 |
Why?
|
| Permeability | 2 | 2011 | 118 | 0.040 |
Why?
|
| Child | 5 | 2020 | 24208 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2020 | 77 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2021 | 384 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2010 | 31 | 0.040 |
Why?
|
| Muramidase | 2 | 2010 | 92 | 0.040 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 254 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 394 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2010 | 153 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 429 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2021 | 697 | 0.040 |
Why?
|
| Leukocyte Rolling | 2 | 2011 | 4 | 0.040 |
Why?
|
| Adolescent | 3 | 2020 | 19086 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 62 | 0.040 |
Why?
|
| Cell Survival | 2 | 2010 | 803 | 0.040 |
Why?
|
| RNA | 1 | 2020 | 577 | 0.040 |
Why?
|
| Macrophages | 1 | 2020 | 607 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 2010 | 1015 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2003 | 2820 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2009 | 692 | 0.030 |
Why?
|
| Progeria | 1 | 2016 | 16 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 2533 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 78 | 0.030 |
Why?
|
| Fibrillin-1 | 1 | 2016 | 58 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 602 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 179 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2016 | 79 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 160 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2016 | 247 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 428 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1695 | 0.030 |
Why?
|
| Hypoxia | 2 | 2007 | 245 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 491 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2016 | 623 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 831 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2016 | 222 | 0.030 |
Why?
|
| Microspheres | 2 | 2005 | 70 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 269 | 0.030 |
Why?
|
| Blood Cells | 1 | 2013 | 50 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 150 | 0.030 |
Why?
|
| Peptides | 2 | 2007 | 798 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1916 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 1684 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 295 | 0.030 |
Why?
|
| Neoplasms | 1 | 2007 | 2770 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 66 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2011 | 77 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 258 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 2698 | 0.020 |
Why?
|
| Glucose | 1 | 2016 | 869 | 0.020 |
Why?
|
| Biotransformation | 1 | 2010 | 49 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 216 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 3871 | 0.020 |
Why?
|
| Half-Life | 1 | 2010 | 156 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 48 | 0.020 |
Why?
|
| Baculoviridae | 1 | 2010 | 64 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2010 | 27 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2010 | 27 | 0.020 |
Why?
|
| Joints | 1 | 2010 | 23 | 0.020 |
Why?
|
| Rheology | 1 | 2010 | 31 | 0.020 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2010 | 25 | 0.020 |
Why?
|
| Solutions | 1 | 2010 | 65 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2010 | 139 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2010 | 28 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 95 | 0.020 |
Why?
|
| Bevacizumab | 1 | 2010 | 63 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2009 | 95 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 94 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 131 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2009 | 204 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 247 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 1735 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4508 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 462 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2010 | 475 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 619 | 0.020 |
Why?
|
| Angiopoietin-1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2007 | 21 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2007 | 40 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 931 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2007 | 37 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2007 | 26 | 0.020 |
Why?
|
| Chlorides | 1 | 2007 | 104 | 0.020 |
Why?
|
| AC133 Antigen | 1 | 2007 | 35 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2007 | 120 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2007 | 110 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 2006 | 26 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 1102 | 0.020 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2006 | 22 | 0.020 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2009 | 194 | 0.020 |
Why?
|
| Neurons | 2 | 2007 | 1927 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 8869 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2006 | 61 | 0.020 |
Why?
|
| Gram-Positive Bacteria | 1 | 2006 | 46 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2007 | 234 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 661 | 0.020 |
Why?
|
| Dependovirus | 1 | 2007 | 130 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2010 | 502 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 382 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 260 | 0.020 |
Why?
|
| Cell Division | 1 | 2006 | 779 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 757 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 715 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2007 | 420 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2007 | 369 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2006 | 372 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 2779 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2006 | 424 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 15981 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 1678 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 617 | 0.010 |
Why?
|
| Physical Phenomena | 1 | 2000 | 1 | 0.010 |
Why?
|
| Physics | 1 | 2000 | 7 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 25980 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 3050 | 0.010 |
Why?
|
| Hematocrit | 1 | 2000 | 110 | 0.010 |
Why?
|
| Linear Models | 1 | 2002 | 671 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 29038 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 1999 | 127 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2002 | 333 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 818 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1679 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 8089 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 6028 | 0.010 |
Why?
|